Keith Regnante
Director of Finance/CFO at KEROS THERAPEUTICS, INC.
Net worth: - $ as of 2024-03-30
Profile
Keith C.
Regnante is currently the Chief Financial Officer at Keros Therapeutics, Inc. He previously worked as the Senior Director-Corporate Finance at Biogen, Inc. from 1999 to 2013, Head-Research & Development Finance at ARIAD Pharmaceuticals, Inc. from 2013 to 2014, Vice President-Finance at Shire Pharmaceuticals, Inc. from 2014 to 2016, and Chief Financial & Accounting Officer at Wave Life Sciences Ltd.
from 2016 to 2020.
He received his undergraduate degree from Tufts University and his MBA from MIT Sloan School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
KEROS THERAPEUTICS, INC.
-.--% | 2024-02-12 | 0 ( -.--% ) | - $ | 2024-03-30 |
Keith Regnante active positions
| Companies | Position | Start |
|---|---|---|
| KEROS THERAPEUTICS, INC. | Director of Finance/CFO | 2020-01-31 |
Former positions of Keith Regnante
| Companies | Position | End |
|---|---|---|
| WAVE LIFE SCIENCES LTD. | Director of Finance/CFO | 2020-01-08 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | 2016-07-31 |
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2014-01-31 |
| BIOGEN INC. | Public Communications Contact | 2013-07-31 |
Training of Keith Regnante
| Tufts University | Undergraduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| WAVE LIFE SCIENCES LTD. | Health Technology |
| KEROS THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
- Stock Market
- Insiders
- Keith Regnante
